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Several genes involved in nitrogen metabolism are known to contribute to the 
virulence of pathogenic bacteria. Here, we studied the function of the nitrogen regulatory 
protein GlnR in the Gram-positive human pathogen Streptococcus pneumoniae. We 
demonstrate that GlnR mediates transcriptional repression of genes involved in glutamine 
synthesis and uptake (glnA, glnPQ), glutamate synthesis (gdhA), and the gene encoding the 
pentose phosphate pathway enzyme Zwf, which forms an operon with glnPQ. Moreover, the 
expression of gdhA is also repressed by the pleiotropic regulator CodY. The GlnR-dependent 
regulation occurs through a conserved operator sequence and is responsive to the 
concentration of glutamate, glutamine and ammonium in the growth medium. By means of in 
vitro binding studies and transcriptional analyses we show that  the regulatory function of 
GlnR is dependent on GlnA. Mutants of glnA and glnP displayed significantly reduced 
adhesion to Detroit 562 human pharyngeal epithelial cells, suggesting a role for these genes 
in the colonization of the host by S. pneumoniae. Thus, our results provide a thorough insight 
into the regulation of glutamine and glutamate metabolism of S. pneumoniae as mediated by 





Regulation of nitrogen metabolism in bacteria is closely connected with the 
intracellular levels of glutamine and glutamate, the main nitrogen donors in the cell. 
Glutamine is formed from glutamate and ammonium by glutamine synthetase (GlnA), which 
is a major way for the cell to assimilate ammonium. Glutamate can be formed either by 
glutamate dehydrogenase from 2-oxoglutarate and ammonium, or by glutamate synthase, 
which converts glutamine and 2-oxoglutarate into two molecules of glutamate.  
Several studies indicate that nitrogen metabolism, especially glutamine metabolism, is 
important for the virulence of various bacterial pathogens (164,313,327). Signature-tagged 
mutagenesis screens suggest that genes involved in glutamine metabolism, glnQ and glnA, 
are likely to play a role in the virulence of S. pneumoniae as well (123,181,254). However, so 
far, glutamine metabolism and the way in which it is regulated have not been studied in this 
human pathogen. 
In the well-characterized Gram-positive bacterium Bacillus subtilis, regulation of 
nitrogen metabolism is carried out mainly by CodY, GlnR and TnrA (91). The latter two are 
members of the MerR family of regulators, and both recognize the same operator sequence: 
‘5-TGTNAN7TNACA-3’. TnrA functions during growth on a poor nitrogen source (e.g. 
solely glutamate) when it activates or represses expression of various genes involved in 
nitrogen metabolism (27,223,287,343,348). GlnR represses its own operon glnRA (50), the 
ureABC operon (encoding urease) (44,342) and tnrA (91) in the presence of a good nitrogen 
source, like glutamine. 
Genetic experiments have shown that genes regulated by GlnR and TnrA are 
constitutively expressed in a mutant of glnA (284-286,343). An explanation for this 
observation came with the discovery that in vitro DNA binding by TnrA is blocked by 
feedback-inhibited GlnA (345). Although it has been suggested that GlnA also controls the 
DNA-binding activity of GlnR, this has never been shown. In fact, B. subtilis GlnR has a high 
affinity for DNA on its own (50). 
B. subtilis CodY functions as a repressor of genes involved in nitrogen metabolism 
(293), but also of carbon and energy metabolism (157), motility (29) and competence 
development (219). In the lactic acid bacterium Lactococcus lactis, CodY represses genes of 
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the proteolytic system and several amino acid transport and metabolism genes, amongst 
others gltA and gltD, which are involved in glutamate biosynthesis (77,103,104). 
Analysis of the S. pneumoniae R6 (133) and TIGR4 (317) genomes revealed that they 
contain genes encoding orthologues of GlnR and CodY, but not of TnrA. Furthermore, S. 
pneumoniae contains a putative orthologue of glnA, several predicted glutamine uptake 
systems and a predicted biosynthetic glutamate dehydrogenase (133,317). In contrast to B. 
subtilis and L. lactis, a gene encoding glutamate synthase is not present. This suggests that S. 
pneumoniae has various ways to warrant sufficient cellular glutamine levels, either by uptake 
from the environment or by de novo synthesis.  
In this study, we report on the important role of GlnR and GlnA in the regulation of 
glutamine and glutamate metabolism in S. pneumoniae, and present indications for a role of 
GlnR targets in pneumococcal virulence.  
 
 
Materials and Methods 
 
Strains, media and growth conditions  
Strains used in this study are listed in Table 1 and were stored in 10% glycerol at -
80ºC. S. pneumoniae was grown essentially as described (161): on plates in a flame-pot, 
giving an elevated CO2 concentration, or in liquid medium as standing cultures. L. lactis and 
E. coli were grown as described previously (161). Kanamycin, spectinomycin and 
tetracycline were used in concentrations of 500 μg/ml, 150 μg/ml and 2.5 μg/ml for S. 
pneumoniae, respectively. Ampicillin was used in a concentration of 100 μg/ml for E. coli. 
Chemically defined medium with a final pH of 6.4 was composed as described (161), except 
that sodium citrate was used in the buffer instead of ammonium citrate and that glutamine 
was omitted from the amino acid mixture. Glutamine, glutamate and ammonium were added 
as specified in the Results section. Induction of gene expression with nisin was performed as 
described, using a stock solution of nisaplin, containing 20 mg/ml nisin (161). 
 
Table 1. Strains and plasmids used in this study. TrmpR, trimethoprim-resistance; SpecR, spectinomycin-
resistance; EmR, erythromycin resistance; TetR, tetracycline resistance; KmR, kanamycin-resistance; CmR, 
chloramphenicol resistance. *Plasmid sequences are available at 
http://molgen.biol.rug.nl/publication/glnRAspn_data. 
Strain/plasmid Description Reference or source 
S. pneumoniae   
D39 Serotype 2 strain, cps2 (19), lab. P. Hermans 
D39repA D39 ∆bgaA::repA; TrmpR (161) 
D39nisRK D39 ∆bgaA::nisRK; TrmpR (161) 
TK100 D39nisRK ∆glnA; SpecR This work 
TK102 D39 glnR-stop, contains two stop mutations in the start of glnR This work 
TK103 D39 ∆glnA; SpecR This work 
TK104 D39 ∆glnRA; SpecR   This work 
TK105 TK102 ∆bgaA::nisRK; TrmpR This work 
TK106 D39 ∆glnP; EmR This work 
TK107 D39 ∆zwf; SpecR This work 
TK108 D39 ∆gdhA; EmR This work 
TK109 TK102 ∆bgaA::repA; TrmpR This work 
WH101 D39 ∆codY; TrmpR   (127) 
TK108 TK102 ∆codY; TrmpR   This work 
TK109 TK106 ∆bgaA::nisRK; TrmpR This work 
TK110 D39nisRK glnA-lacZ; EmR   This work 
TK111 D39nisRK PglnP-lacZ; EmR     This work 
TK112 D39nisRK gdhA-lacZ; EmR   This work 
TK113 D39nisRK zwf-lacZ; EmR   This work 
TK114 D39nisRK ParcA-lacZ; EmR  This work 
TK120 TK105 glnA-lacZ; EmR  This work 
TK121 TK105 PglnP-lacZ; EmR   This work 
TK122 TK105 gdhA-lacZ; EmR  This work 
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TK123 TK105 zwf-lacZ; EmR  This work 
TK125 TK105 ParcA-lacZ; EmR  This work 
TK126 TK100  glnA-lacZ; EmR  This work 
TK127 TK100 PglnP-lacZ; EmR  This work 
TK129 TK100 gdhA-lacZ; EmR  This work 
TK130 TK100 zwf-lacZ; EmR  This work 
TK131 TK100 ParcA-lacZ; EmR  This work 
TK132 D39 ∆bgaA::PgdhA1-lacZ; TetR  This work 
TK133 D39 ∆bgaA::PgdhA1-lacZ; TetR  This work 
TK134 TK102 ∆bgaA::PgdhA2-lacZ; TetR  This work 
TK135 TK102 ∆bgaA::PgdhA2-lacZ; TetR  This work 
TK136 D39 ∆cps; KmR capsule-less derivative This work 
TK137 TK102 ∆cps; KmR capsuleless derivative This work 
TK138 TK103 ∆cps; KmR capsuleless derivative This work 
TK139 TK104 ∆cps; KmR capsuleless derivative This work 
TK140 TK106 ∆cps; KmR capsuleless derivative This work 
L. lactis   
NZ9000 MG1363∆pepN::nisRK (171) 
LL108 MG1363 RepA+ (multi-copy); CmR (186) 
E. coli   
EC1000 KmR; MC1000 derivative carrying a single 
copy of the pWV01 repA gene in glgB 
(187) 
   
Plasmids   
pORI13 EmR; ori+ repA-; promoterless lacZ, for single-copy chromosomal 
lacZ fusions. 
(277) 
pORI280 EmR; ori+ repA-; deletion derivative of pWV01; constitutive lacZ 
expression from P32 promoter 
(187) 
pORI28* EmR; ori+ repA-; deletion derivative of pWV01 (187) 
pORI38* SpecR; ori+ repA-; deletion derivative of pWV01 (187) 
pNZ8048 CmR; Nisin-inducible PnisA (74) 
pNG8048E CmR EmR; Nisin-inducible PnisA, pNZ8048 derivative containing emR 
gene to facilitate cloning 
Laboratory collection 
pPP2 AmpR TetR; promoter-less lacZ. For replacement of bgaA (spr0565) 
with promoter-lacZ fusions. Derivative of pPP1. 
(167) 
pORI28spec1* pORI28 containing specR gene from pORI38 This work 
pTK8 pORI13 ’glnA-lacZ This work 
pTK9 pORI13 PglnP-lacZ This work 
pTK10 pORI13 ’gdhA-lacZ This work 
pTK11 pORI13 ’zwf-lacZ This work 
pTK12 pORI13 ParcA-lacZ This work 
pTK13 pPP2 PgdhA-1-lacZ This work 
pTK14 pPP2 PgdhA-2-lacZ This work 
pTK15 pNG8048E carrying His6-glnA downstream of  PnisA This work 
pTK16 pNG8048E carrying His6-glnR downstream of  PnisA This work 
pTK17 pNG8048E carrying glnPQ downstream of  PnisA This work 
pTK18 pORI28spec1 containing 886 bp downstream of glnA This work 
pTK19 pORI28spec1 ∆zwf This work 
pTK20 pORI280, containing glnR with stop mutations 
(K20(AAG)stop(TAG) and L21(TTG)stop (TAG)) 
This work 
pTK21 pORI13 Pzwf-lacZ This work 
pTK22 pORI28spec1 containing 883 bp upstream sequence of glnR  This work 
pTK23 pNG8048E carrying glnR downstream of  PnisA This work 
 
Table 2. Oligonucleotide primers used in this study. *Stop-mutations are indicated in bold. Overlap of primers 
glnR-stop 1 and 2 is in italics. #6xHis-tag in bold. $Extra codon for lysine in italics. **Overlap with emR gene 
from pORI28 in bold. 
Name Nucleotide sequence (5’ to 3’); 
restriction enzyme sites underlined 
Restriction site 
Ery-for GCATGCATCGATTAGATCTC - 
Ery-rev TAACGATTATGCCGATAACT - 
Spec_pORI38-Fp CCCCAAGCTTCTAATCAAAATAGTGAGGAGG HindIII 
Spec_pORI38-Rp CCCCAAGCTTACTAAACGAAATAAACGC HindIII 
R6_glnA-5 TGCTCTAGACTTTCTTCTATATTAGTATTAGTAAAGGTC XbaI 
R6_glnA-6 CGGAATTCGGTATTGCTGGATCAGGTATGCAC EcoRI 
R6_PglnP-1 CGGAATTCCGAAAGTCACTTGTTTTATCC EcoRI 
R6_PglnP-2 TGCTCTAGAAGGACATCTGAATGTTCCAGC XbaI 
R6_gdhA-4 CGGAATTCCGATGAAAACGGTATCGACTTCG EcoRI 
R6_gdhA-5 TGCTCTAGACTTAAACAATACCTTGTGCAATCATAGC XbaI 
R6_G6PDH-1 CGGAATTCGCTCTGGTAAGATTGATGG EcoRI 
R6_G6PDH-2 TGCTCTAGATTTTTATTCTAAGCGACCATC XbaI 
R6_arcA-3 TGCTCTAGACCGAGAAGACCTGAATTGGATGTG XbaI 
R6_arcA-4 CGGAATTCGGTAGGCTCAGGATTTTTCTCC EcoRI 
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Pg6pdh-1 CGGAATTCGAAAGAGTTCTTAGATAAGG EcoRI 
Pg6pdh-2 TGCTCTAGACGAAAATTGTAACAATAACC XbaI 
glnP-OX1 CGAGCCATCATGAAGAAAAAATTTCTAGCATTTTTGC RcaI 
glnP-OX2 TGCTCTAGAGTAGAAAAACTGCAAGGAAATCC XbaI 








glnA_R6-8 GCTCTAGATGTGACTGTTTACCCACAG XbaI 
glnA_R6-1 GAATTCCATATGGGAAATAGTATCGGTGGAC NdeI 
glnA_R6-2 CGGCGACGTCGCAGCTGTGATTGGCATAAG AatII 
glnA_R6-3 CATGCCATGGGGAAATTGATAATTATTTAGACC NcoI 
glnA_R6-4 GAAGATCTCTAGACGTATCTATATACC BglII 
glnR_R6-1 TGCTCTAGAGGTGGTGACTCAGCTGCCGC XbaI 
glnR_R6-2 CGGGATCCCCTTCATTTACAATTTCCTTC BamHI 
glnR-stop 1* CGGTCTACTACATAACACTGCCGATAGGAAAAACAGCC - 
glnR-stop 2* CAGTGTTATGTAGTAGACCGATCTATCGGCGCGTCAG - 
glnR-3 GAAGATCTACTTCAAGTGTTGGGTCCCC BglII 
glnPKO-1 AAAAAGTGCCAAGCCTAGAC - 
glnPKO-2** GAGATCTAATCGATGCATGCTACCTAATGAGAAAATTGGG - 
glnPKO-3** AGTTATCGGCATAATCGTTACGAAACGCTTAGAAAAGAGG - 
glnPKO-4 TAATCATGGTCATGCCTTGC - 
gdhAKO-1 GATCGATTTGCCCTGTTCTTG - 
gdhAKO-2** GAGATCTAATCGATGCATGCGCAGATGTCATATCGTTCTCC - 
gdhAKO-3** AGTTATCGGCATAATCGTTACTATGATTGCACAAGGTATTG - 
gdhAKO-4 AAGGAGTAGAGATGGCTATAG - 
G6PDH-4  TGCTCTAGACCAACACTTCAACCTCTTCCC XbaI 
G6PDH-5  CGGGATCCCCGAAAATTGTAACAATAACC BamHI 
G6PDH-6 CATGCCATGGTCACCTATCGTCAAGATGGTCG NcoI 
G6PDH-7 GAAGATCTGGCCCACCGCTACAAACAAGC BglII 
PgdhA-2 TGCTCTAGATCTTTAGCAGATGTCATATC XbaI 
PgdhA-3 TGCTCTAGACATAAGACATTATAGCAG XbaI 
PgdhA-4 CGGAATTCGATATTTCCAAGAAAAACGTTCG EcoRI 
PE21 CTGGAACAACCATGACCTCCCTCG - 
FI4 CGCTGAACTTTTGTAGTTGCTTGGTCAAC - 
R6_glnP-1 CGGAATTCCATTTTTGAAGCTTGGAAGTC Footprinting 
R6_glnR-7 GCTCTAGACTGCCGATAGGAAAAACAGCC Footprinting 
R6_PglnR_FP TTGTACGTGTTTGTGCGTG Footprinting 
R6_glnP-GFP1 CGGAATTCCATTTTTAGTCTCCTTTTCCG Footprinting 
PglnR-2 CGGAATTCCGATATTGATCGTATTCGTC EMSA 
PglnR-3 CGGAATTCATTATCAATTGACGTTTGTC EMSA 
PglnPQ-1 CGGAATTCGGCACTTTTTAATAGCAATTCAAG EMSA 
PglnPQ-2 TGCTCTAGAGGAATAAAATTAGCAAAAATGC EMSA 
PglnPQ-3 CGGAATTCGCGAAAAATATAACAATTTGCC EMSA 
 
DNA isolation and manipulation 
Primers used in this study are listed in Table 2. Primers were based on the genome 
sequence of strain S. pneumoniae R6 (133). Unless otherwise indicated, chromosomal DNA 
of S. pneumoniae D39 was used as a template for PCR amplification. All DNA manipulations 
were done as described (161). 
 
Construction of glnR, glnA, glnRA, zwf and glnP mutants of S. pneumoniae 
The glnR-stop mutant (TK102) was constructed using plasmid pORI280 as follows. 
Primer glnR-stop 1 with two point mutations, leading to two premature stop codons at codon-
positions 20 and 21 in the glnR reading frame, was used in combination with primer 
glnR_R6-1 to PCR amplify a fragment comprising the upstream part and the beginning of 
glnR. A second PCR product, comprising the rest of the glnR gene and part of the 
downstream sequence, was produced with primers glnR-stop 2 and glnR-3. These PCR 
products were complementary by 20-bp covering the position of the stop codons and were 
used as a template in a PCR reaction with primers glnR_R6-1 and glnR-3. The resulting 
product was cloned as an XbaI/BglII fragment in pORI280, giving plasmid pTK20. pTK20 
was used to introduce the mutations into the chromosome of S. pneumoniae D39 as described 
(161), giving strain TK102. The mutations led to the disappearance of a HincII site, on the 
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basis of which the proper mutant could be identified. The mutations were further verified by 
DNA sequencing. 
The glnA deletion strain (TK103) was generated by allelic-replacement mutagenesis, 
removing 1300 bp of the glnA ORF: A PCR fragment, generated with primers Spec_pORI38-
Fp and Spec_pORI38-Rp on the spectinomycin resistance gene from pORI38, was cloned 
into the HindIII site of pORI28 in the same orientation as the erythromycin gene on this 
vector, yielding pORI28spec1. Next, the 3’ flanking region of glnA, amplified with primer 
pair glnA_R6-3/glnA_R6-4 (886 bp), was cloned into the NcoI/BglII sites of pORI28spec1, 
giving pTK18. pTK18 was cut with NdeI/AatII and a PCR fragment generated with primers 
glnA_R6-1/glnA_R6-2 (808 bp), which was digested with the same enzymes, was ligated to 
it. This ligation mixture was used to generate a PCR product with primers glnA_R6-1 and 
glnA_R6-4, which was transformed to S. pneumoniae D39. Spectinomycin resistant clones 
were examined for the presence of the glnA deletion by PCR and Southern blotting. The zwf 
deletion mutant (TK107), removing 1416 bp of the zwf ORF, was constructed in a similar 
way as the glnA mutant, using primers G6PDH-4/G6PDH-5 (660 bp) and G6PDH-6/G6PDH-
7 (610 bp). 
To construct the glnRA mutant (TK104), the upstream part of glnR, amplified with 
primer pair glnR_R6-1/glnR_R6-2 (883 bp), was cloned into the XbaI/BamHI sites of 
pORI28spec1, giving pTK22. pTK22 was used together with pTK18, which contains the 
glnA_R6-3/glnA_R6-4 PCR product cloned into the NcoI/BglII sites of pORI28spec1, as a 
template in a PCR reaction with primers glnR_R6-1 and glnA_R6-4. In this way a PCR 
product was obtained containing the spectinomycin resistance gene flanked by the upstream 
and downstream sequence of glnRA. The resulting PCR product was transformed to D39. The 
deletion was confirmed by PCR and Southern blotting. 
L. lactis 108 was used as the cloning host for plasmid pTK19. All other construct 
were made in E. coli EC1000. 
To construct the glnP deletion mutant (TK106), removing 2080 bp of the glnP ORF, a 
PCR fragment, generated with primer pair Ery-rev/Ery-for on the erythromycin resistance 
gene from pORI28, was fused to the flanking regions of glnP, which were PCR amplified 
with primer pairs glnPKO-1/glnPKO-2 (628 bp) and glnPKO-3/glnPKO-4 (610 bp), by 
means of overlap-extension PCR (298). The resulting PCR product was transformed to S. 
pneumoniae D39, and clones were checked for the presence of the mutation by PCR. In the 
same way a deletion mutant of gdhA, removing 1311 bp of the gdhA ORF, was constructed in 
D39 using primer pairs gdhAKO-1/gdhAKO-2 (479 bp) and gdhAKO-3/gdhAKO-4 (498 bp). 
Construction of capsuleless derivatives of D39 and its glnA, glnR, glnRA and glnP 
mutants was done as described (250), using primers PE21 and FI4. Mutants were checked by 
PCR and appearance. In addition, they adhere several orders of magnitude better than the 
encapsulated mutants.  
 
Construction of lacZ fusions 
Chromosomal transcriptional lacZ fusions were constructed with the integration 
plasmid pORI13 as described (161,277). For lacZ fusions to glnA, gdhA and zwf, 600 to 800-
bp fragments of the 3’ ends of the genes were PCR amplified using primer pairs R6_glnA-
5/R6_glnA-6, R6_gdhA-4/R6_gdhA-5 and R6_G6PDH-1/R6_G6PDH-2, respectively. These 
fragments were digested and cloned into the XbaI/EcoRI sites of PORI13, giving pTK8, 
pTK10, pTK11, respectively. The constructs were introduced into S. pneumoniae D39nisRK, 
and D39nisRK containing either the glnA (TK100) or glnR (TK105) mutation and clones 
were checked by PCR. Analogously, pTK9 and pTK12 were constructed with primers 
R6_PglnP-1/R6_PglnP-2 and R6_arcA-3/R6_arcA-4. These plasmids were used to generate 
chromosomal lacZ fusions to the glnP and arcA promoters. 
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The glnQ-zwf intergenic region was cloned into pORI13 using primers Pg6pdh-1/ 
Pg6pdh-2, giving pTK21. 
The lacZ fusions to the gdhA promoter were constructed in pPP2 with primer pair 
PgdhA-2/PgdhA-4, giving a PCR product comprising the full-length promoter (PgdhA-1), 
and primer pair PgdhA-3/PgdhA-4, resulting in a PCR product without the predicted GlnR 
operator (PgdhA-2), using E. coli EC1000 as the cloning host. The constructs were introduced 
in S. pneumoniae strains D39 and TK102. 
 
Construction of overexpression constructs 
The glnR, glnA and glnPQ genes were PCR amplified with primer pairs glnR-9-
his/glnR_R6-10, glnA-his/glnA_R6-8 and glnP-OX1/glnP-OX2, respectively, and cloned into 
the NcoI/XbaI sites of pNG8048E, giving pTK16, pTK15 and pTK17. In addition, the native 
glnR gene  was cloned into pNG8048E using primers glnR-_R6-9/glnR_R6-10, giving 
pTK23. 
 
Purification of GlnR and GlnA 
Overexpression of N-terminally 6xHis-tagged GlnR and GlnA (H6-GlnR and H6-
GlnA) was achieved with the nisin-inducible system (NICE) in strain L. lactis NZ9000 (171). 
Expression was induced with nisin in 1 L cultures at an OD600 of 0.6, using a 10-7 dilution (2 
ng/ml) of nisaplin, which was prepared as described (161). After two hours of induction, cells 
were harvested and resuspended in 10 ml buffer A (0.25 M NaCl, 10 mM MgCl2, 20 mM 
Tris-HCl, pH 8, 10% glycerol, 1 mM -mercaptoethanol) with 1 mg/ml lysozyme and 1 
tablet of protease inhibitor cocktail (Complete Mini, Roche). After 20 min of incubation on 
ice, cells were disrupted by shaking 5 times 1 min with 400 mg glass-beads (75-150 μm, 
Fischer Scientific BV) per ml of cell suspension in a Biospec Mini-BeadBeater-8 (Biospec 
Products) and cell debris was removed by centrifugation. 1 ml Ni-NTA beads (Qiagen), pre-
equilibrated in buffer A, was added to the cell lysate and protein binding was allowed for 1h 
at 4ºC, with continuous gentle shaking. Beads were washed 10 times with buffer A 
containing 20 mM imidazole after which H6-GlnR and H6-GlnA were eluted with buffer A 
containing 250 mM imidazole and subsequently with buffer A containing 350 mM imidazole. 
H6-GlnA was dialysed against 2,000 times excess of buffer B (20 mM Tris-HCl, pH 8.5, 10% 
glycerol, 1 mM -mercapto-ethanol) for 6 hrs at 4ºC. Since H6-GlnR precipitated during 
dialysis, imidazole was removed by means of a PD-10 desalting column (Amersham 
Biosciences), using buffer C (20 mM Tris-HCl, pH 7.5, 10% glycerol, 10 mM MgCl2, 1 mM 
EDTA, 1 mM -mercapto-ethanol), in which way precipitation was not observed. Purified 
fractions contained >95% pure protein of the expected size with a concentration of between 
0.2 and 1 mg protein/ml. 
 
Electrophoretic mobility shift assays and DNAseI footprinting 
EMSAs were performed essentially as described previously (76). PCR products of 
PglnR with and without the predicted GlnR operator were made with primer pairs glnR_R6-
2/PglnR-2 (PglnR-1, 146 bp) and glnR_R6-2/PglnR-3 (PglnR-2, 84 bp), respectively. In the 
same way, PCR products spanning PglnP were generated with primer pairs PglnPQ-
1/PglnPQ-2 (PglnP-1, 190 bp) and PglnPQ-2/PglnPQ-3 (PglnP-2, 131 bp), respectively. The 
binding buffer was composed of 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 1 mM dithiotreitol 
(DTT), 8.7% (w/v) glycerol, 62.5 mM KCl, 25 µg/ml bovine serum albumin, 50 µg/ml 
poly(dI-dC) and 3,000-5,000 cpm of [γ-32P]ATP-labeled PCR product. Glutamine, glutamate, 
ammonium and purified H6-GlnR and H6-GlnA were added as specified in the Results 
section. Reactions (20 µl) were incubated for 20 min at 25ºC after which they were run on a 
6% poly-acrylamide gel for 75 min at 90V. 
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DNAseI footprinting was done essentially as described (76). 150,000 cpm of [γ-
32P]ATP-labeled PCR products of the glnR and glnP promoters, made with primer pairs 
R6_PglnR_FP/R6_glnR-7 (244 bp) and R6_glnP-1/R6_glnP-GFP1 (235 bp), respectively, 
were used as probes in 40 μl binding buffer (EMSA) containing 5 mM glutamine and purified 
H6-GlnR and H6-GlnA as specified in the Results section. 
 
Enzyme assays 
Cell-free extracts, used for the determination of glutamine synthetase (GlnA), 
biosynthetic glutamate dehydrogenase (GdhA) and glucose-6-phosphate dehydrogenase 
(Zwf) activity, were made from 1 or 2 ml of cells harvested in exponential phase of growth, 
which were resuspended in 250 μl 20 mM Tris (pH 7.5) and disrupted by shaking 1 min with 
400 mg glassbeads (75-150 m) in a Biospec Mini-BeadBeater-8. After removal of cell-
debris by centrifugation, cell-free extracts were used in a concentration of 1/10 to 1/20 of the 
total volume of the assay mixture. The OD600 at which cells were harvested was used to 
calculate the enzyme activity per OD600 unit. Standard deviations were calculated from at 
least three independent replicate experiments. GlnA activity (transferase reaction) was 
determined as described (92). Biosynthetic glutamine synthetase activity of purified H6-GlnA 
(ATP + L-glutamate => ADP + Pi + L-glutamine) was determined as described (82). 
Biosynthetic GdhA activity (2-oxoglutarate + NADPH + NH4+ => glutamate + NADP+) was 
determined at 30ºC in a reaction mixture containing 50 mM Tris-HCl (pH 8.5), 35 mM 2-
oxoglutarate, 80 mM NH4Cl and 0.3 mM 2’-NADPH, by monitoring the decrease in 
absorption at 340 nm (A340) caused by oxidation of NADPH. Catabolic GdhA activity was 
measured at 30ºC in a reaction mixture containing 50 mM Tris-HCl (pH 7.5), 70 mM L-
glutamate, and 0.5 mM NADP+, by monitoring the increase in A340. Activity of Zwf (glucose-
6-P + NADP+ => gluconolactone-6-phosphate + NADPH) was measured in buffer containing 
1 mM NADP+, 2 mM glucose-6-phophate, 10 mM MgCl2, 1 mM DTT and 20 mM Tris-HCl 
(pH 8.0), by monitoring the increase in A340 at 30ºC. Activity of -galactosidase was 
determined as described (137), except that cells were permeabilized with a final 
concentration of 0.06 mg/ml CTAB (cetyltrimethyl ammonium bromide). During growth for 
-galactosidase assays, no antibiotic selection was imposed.  
 
Transcriptome analysis using S. pneumoniae DNA microarrays 
DNA microarray experiments were performed essentially as described (332). RNA 
was isolated from 50 ml of cells grown to mid-exponential phase of growth (OD600 = 0.3) in 
GM17 containing 0.5 mg/ml glutamine (GM17Gln). Cells were harvested by centrifugation 
for 1 min at 10,000 rpm at room temperature. Cell pellets were immediately frozen in liquid 
nitrogen and stored at -80C. Pellets were resuspended in 500 l 10 mM Tris-HCl, 1 mM 
EDTA (T10E1), pH 8.0, after which 50 l 10% SDS, 500 l phenol/chloroform, 500 mg glass 
beads (75-150 m), and 175 l Macaloid suspension (Bentone MA) were added.  
Synthesis of cDNA and indirect Cy-3/Cy-5-dCTPs labeling of 15-20 g total RNA 
was performed with the CyScribe Post Labeling Kit (Amersham Biosciences) according to 
the supplier’s instructions. Hybridization (16 h at 45C) of labeled cDNA was performed in 
Ambion Slidehyb #1 hybridisation buffer (Ambion Europe) on super-amine glass slides 
(Array-It, SMMBC), containing technical replicates of amplicons representing 2087 ORFs of 
S. pneumoniae TIGR4 and 184 ORFs unique for S. pneumoniae R6. DNA microarrays were 
produced essentially as described (170,332). Amplicon sequences are available at 
http://molgen.biol.rug.nl/publication/glnRAspn_data. Slides were scanned using a GeneTac 





DNA microarray data analysis 
Slide images were analyzed using ArrayPro 4.5 (Media Cybernetics Inc., Silver 
Spring, MD). Processing and normalization (LOWESS spotpin-based) of slides was done 
with the in-house developed MicroPrep software as described (332,333). DNA microarray 
data were obtained from three independent biological replicates hybridized to three glass 
slides, of which one was a dye-swap. Expression ratios of mutant strain over the wild-type 
strain were calculated from the measurements of at least 5 spots. Differential expression tests 
were performed on expression ratios with a local copy of the Cyber-T implementation of a 
variant of the t-test. False discovery rates (FDRs) were calculated as described (332). A gene 
was considered differentially expressed when p <0.001 and FDR <0.05 and when at least 5 
measurements were available. The DNA microarray data are available at 
http://molgen.biol.rug.nl/publication/glnRAspn_data. In addition, they have been deposited in 




RNA isolation and cDNA synthesis was performed as described above, except that 
aminoallyl-dUTP was replaced by dTTP during cDNA synthesis. To confirm the absence of 
DNA contamination, reactions were also carried out without reverse transcriptase. 100 ng 
cDNA was used for each PCR reaction, and after 20 amplification cycles (30 sec, 95ºC; 30 
sec, 52ºC;, 60 sec, 72ºC) with primers G6PDH4 and G6PDH5 reactions were analyzed on 1% 
agarose gels.  
 
Adhesion assays 
Adhesion of pneumococci to epithelial cells was studied essentially as described 
previously (156). Briefly, the human pharyngeal cell line Detroit 562 (ATCC CCL-138) was 
cultured in RPMI 1640 without phenol red (Invitrogen) containing 1 mM sodium pyruvate 
and 10% fetal calf serum (FCS).  Aliquots of bacteria, grown to mid-exponential phase in 
GM17 and stored till use at -80°C, were thawed rapidly, harvested by centrifugation, and 
resuspended to 1x107 CFU/ml in RPMI 1640 medium without phenol red containing 1% 
FCS. Monolayers of Detroit 562 in 24-well tissue culture plates were washed twice with 1 ml 
PBS, after which 1 ml of bacterial suspension was allowed to adhere for 2h at 37°C in a 5% 
CO2 atmosphere. Subsequently, non-adherent bacteria were removed by three washes with 
1 ml PBS, and the epithelial cells were detached by treatment with 200 μl of 25% Trypsin, 1 
mM EDTA in PBS. Detroit 562 cells were lysed by the addition of 800 μl of ice-cold 0.025% 
Triton X-100 in PBS, and appropriate dilutions were plated on blood agar plates to count the 
number of adherent bacteria. This CFU count was first corrected mathematically to account 
for small differences in count in the initial inoculum, after which data were normalized so 
that the adhesion of the wild-type strain TK136 was expressed as 100%. Wild-type and 
mutant pneumococci grew comparably in RMPI medium without Detroit 562 cells. All 
experiments were performed in triplicate and repeated at least three times. Significant 






Prediction of putative GlnR operators in S. pneumoniae 
B. subtilis GlnR is known to repress genes that contain two copies of the inverted 
repeat 5’-TGTNAN7TNACA-3’ in their promoters (44,50). This repeat is also present in the 
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PglnR 
           →PglnR-1                                             
-127  AATTACGATATTGATCGTATTCGTCTCTTTTTAGAGAAAAAAGAAAAATAATGTTACATTTTA 
                                                               ↑ 
          →PglnR-2 
-64   TAACATTATCAATTGACGTTTGTCTTTTTTTAGACTATAATAGACAGAAAGAAGGAAATTGTA 
 
 




               →PglnP-1                                        
-142  ATTATTATAGCACTTTTTAATAGCAATTCAAGAAAGAAAAGGAAAAATCAATGTTATATTTTC 
                                                              ↑ 
           →PglnP-2         
-79   TGACACGAAAAATATAACAATTTGCCTTTTTTTACTTTTTCTGATATAATGAGAGAATATTCG 
         ↑       ↑       ↑    
 




                                                                   
-104  GAATTGAAAGAATTTTTAGAAAATTTCTGTTTTTTCTTTACAGTGAAAAAAAATTCTGCTATA 
  
               ←PgdhA-2                                        ←PgdhA-1 





-168  ATTCCATCCTATGTTATGTATAATAACATAAAGTTGTGCTAAATATCATAATTTATATTATTT 
 
-105  TCCGAGAAATTATAGCCATTGACATTACCTAGGAATTGCGTTATAATATACATGTAAGCGGTA 
 
-42   TGGTGCCCCCAAAAAAGTCAAAATTTTTAAGGAGGAAAATACATG--->arcA
promoter regions of the Lactobacillus rhamnosus (334) and Bacillus cereus (224) glnRA 
operons. As the GlnR binding box seems so well conserved between species, we screened the 
entire genome of S. peumoniae R6 for the presence of putative GlnR operators using 
Genome2D (20). Predicted operators with the highest similarity to the B. subtilis consensus 
sequence were present in the promoter regions of glnR (spr0443); glnP (spr1120), encoding a 
glutamine ABC transporter substrate binding protein; gdhA (spr1181) encoding a NADP(H)-
specific glutamate dehydrogenase; and arcA (spr1955, spr1956), encoding arginine 
deiminase (Fig. 1). Re-searching the R6 genome with a weight matrix built from these 


























Figure 1. Nucleotide sequences of the promoter regions of the indicated genes/operons of S. pneumoniae R6. 
Predicted -35 and (extended) -10 core promoter regions are underlined. Putative GlnR operators are boxed. 
Translational starts are in italic. Numbers indicate the base-positions relative to the translational start. A 
predicted CodY operator in the gdhA promoter is underlined with a dotted line. Bases in PglnR and PglnP that 
are in bold were protected in the DNAseI footprinting analyses (Fig. 6B) and vertical arrows below the 
sequences indicate hypersensitive bases. Horizontal arrows above PglnR (PglnR-1 and PglnR-2), PglnP (PglnP-
1 and PglnP-2) and PgdhA (PgdhA-1 and PgdhA-2) indicate the locations of the primers used to make the 
promoter truncations as used for Fig. 4C and 6A. 
 
The regulon of GlnR and GlnA in S. pneumoniae 
To investigate the role of GlnR in S. pneumoniae in more detail, we constructed a 
glnR mutant in strain D39. To preserve the glnRA operon structure, two consecutive stop-
codons were introduced in the beginning of the glnR open reading frame (ORF), specifying 
amino acids in the middle of the predicted helix-turn-helix DNA-binding motif.  
DNA microarray analyses were performed of S. pneumoniae D39 wild-type and its 
isogenic glnR mutant grown in the nitrogen-rich medium GM17, supplemented with 0.5 
mg/ml glutamine (GM17Gln). This amino acid is assumed to be a co-repressor of GlnR in B. 
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subtilis (284), and we expected it to also induce repression of GlnR targets in S. pneumoniae. 
The operons/genes that were most highly upregulated in the glnR mutant were glnRA, glnPQ, 
and gdhA (Table 3), all of which have a GlnR operator in their promoter regions (Fig. 1). The 
arcA gene, which also contains a putative GlnR operator in its promoter, was only weakly 
upregulated. Remarkably, also zwf, encoding the key enzyme glucose-6-phosphate 
dehydrogenase of the pentose phosphate pathway, was upregulated. This gene lies 
downstream of and in the same orientation as glnPQ. 
 
Table 3. Summary of transcriptome comparison of S. pneumoniae strains D39 glnR-stop and D39 ∆glnA with 
D39 wild-type. aGene numbers refer to TIGR4 locus tags. bTIGR annotation. cRatios >1.5 or <-1.5 (D39 glnR-
stop compared to D39) in bold, p-values in parenthesis. dRatios >1.5 or <-1.5 (D39 ∆glnA compared to D39) in 
bold, p-values in parentheses. eNDE, not significantly differentially expressed. 
Gene namea Functionb glnR-stopc glnAd 
SP0092 ABC transporter, substrate-binding protein  1.5 (3.1e-7)   NDE e 
SP0237 Ribosomal protein L17  1.5 (2.0e-8) NDE 
SP0295 Ribosomal protein S9  1.6 (3.6e-9)  1.6 (4.3e-5) 
SP454 Hypothetical protein  1.5 (2.2e-4) NDE 
glnR (SP0501) Nitrogen regulatory protein  5.0 (0.0)  1.7 (3.8e-4) 
glnA (SP0502) Glutamine synthetase  5.1 (0.0) -2.4 (5.3e-5) 
SP0922 Carbon-nitrogen hydrolase family protein NDE  1.6 (2.0e-5) 
SP0964 Dihydroorotate dehydrogenase NDE  1.8 (7.3e-6) 
SP0965 Endo-beta-N-acetylglucosaminidase -1.6 (2.4e-8) NDE 
SP1111 Hypothetical protein NDE -3.7 (5.0e-4) 
glnP(SP1241) Glutamine ABC transport and substrate 
binding prot. 
 4.3 (2.8e-15)  2.8 (3.6e-12) 
glnQ (SP1242) Glutamine ABC transport and substrate 
binding prot. 
 4.0 (0.0)  2.5 (8.4e-11) 
zwf (SP1243) Glucose-6-phosphate dehydrogenase  2.8 (4.7e-15)  1.6 (7.3e-7) 
SP1275 Carbamoyl-phosphate synthase large 
subunit 
 2.4 (1.6e-5)  1.5 (7.9e-7) 
SP1276 Carbamoyl-phosphate synthase small chain  NDE  1.6 (1.4e-8) 
SP1277 Aspartate carbamoyltransferase   1.8 (1.1e-4)  1.8 (5.0e-7) 
gdhA (SP1306) NADPH-dependent biosynthetic glutamate 
dehydrogenase 
 2.2 (6.9e-12)  2.0 (1.0e-9) 
SP1354 Ribosomal protein L7/L12  1.8 (3.1e-9) NDE 
SP1936 Type II restriction-modification system 
regulatory protein 
 1.6 (9.3e-6) NDE 
SP2055 Alcohol dehydrogenase, zinc-containing  1.5 (2.2e-6) NDE 
SP2060 Pyrrolidone-carboxylate peptidase NDE -1.7 (2.8e-5) 
SP2063 LysM domain protein, authentic frameshift -1.9 (1.1e-11) -2.3 (6.5e-9) 
arcA (SP2148) Arginine deiminase  1.6 (4.4e-4) NDE 
 
To investigate the influence of GlnA on the expression of the identified GlnR targets, 
a comparison of the transcriptomes of wild-type D39 with its isogenic glnA mutant, grown in 
GM17Gln, was performed. This showed that glnR, glnP, glnQ and gdhA were, like in the 
glnR mutant, also upregulated in the glnA mutant (Table 3), indicating that GlnA is necessary 
for the functioning of GlnR. 
Besides the genes mentioned above, SP2063, encoding a predicted LysM domain 
containing protein, not directly involved in glutamine metabolism, was twofold 
downregulated in both the glnR and the glnA mutant. Interestingly, two degenerate GlnR 
boxes (5’-TGTGACAGAGACCTAACA-3’ and 5’-TGTTATTAGCGTCAACA-3’) are 
present in the promoter region of this gene.  
In both the glnR and glnA mutant, genes predicted to encode proteins involved in 
pyrimidine metabolism (SP1275, SP1276, SP1277, SP0954) were moderately upregulated, 
which seems logical as glutamine is a precursor of pyrimidine. However, as no GlnR operator 
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could be identified upstream of any of these genes, the upregulation is likely to be an indirect 
effect caused by altered intracellular glutamine/glutamate levels. Furthermore, a number of 
other genes of various functions were moderately upregulated in either the glnR or the glnA 
mutant.  
Chromosomal transcriptional lacZ fusions were used to confirm that in both the glnR 
and the glnA mutant, expression of glnA, glnP, zwf and gdhA was de-repressed (Fig. 2A, 3A, 
3B, 4A).  In addition, enzymatic activity assays showed that the observed effects on 
transcription corresponded with altered activities of GlnA, GdhA and Zwf in the glnR and 
glnA mutants (Fig. 2B, 3C, 4B). No strong effect of the glnR or the glnA mutation on the 
expression of a chromosomal ParcA-lacZ transcriptional fusion was observed in a range of 






















































































Figure 2. Expression of glnA in S. pneumoniae D39 (black bars) and its glnR (white bars) and glnA (diagonally 
hatched bars) mutants in various media. (A) β-galactosidase activity in strains TK110 (D39nisRK glnA-lacZ) 
and TK120 (D39nisRK glnR-stop glnA-lacZ) in CDM supplemented with 10 mM glutamate (glu10), 0.25 mM 
glutamine (Gln0.25), 5 mM glutamine (Gln5), 10 mM glutamate and 10 mM NH4Cl (Glu10am10), 5 mM 
glutamine and 10 mM NH4Cl (Gln5am10), and in GM17 with 0.5 mM glutamine (GM17Gln), which is 
indicated at the x-axis. (B) GlnA activity in strains D39, TK102 (D39 glnR-stop) and TK103 (D39 ∆glnA) in the 
media indicated on the x-axis. 
 
Nitrogen source-dependent regulation of glnRA and glnPQ by GlnR 
To address the role of GlnA substrates in the observed GlnR-dependent regulation in 
S. pneumoniae, expression of the chromosomal glnA-lacZ and glnP-lacZ fusions was 
measured in a chemically defined medium (CDM), to which glutamine, glutamate and 
ammonium were added in varying amounts (Fig. 2A). In CDM with only glutamate, glnA 
expression was similar in the wild-type and the glnR mutant. In contrast, glutamine led to 
repression of glnA expression in the wild-type already at a relatively low concentration (0.25 
mM). A higher glutamine concentration did not lead to stronger repression in the wild-type. 
However, when besides glutamine ammonium was included, glnA expression could be 
further repressed. The combination of glutamate and ammonium also gave rise to repression 
of glnA expression in the wild-type. None of the above combinations caused repression of 
glnA expression in the glnR mutant. GlnA enzymatic activity is regulated in the same way 
(Fig. 2B). 
Regulation of glnP in response to glutamate, glutamine and ammonium is very similar 
to that of glnA (Fig. 3A). Derepression of glnP expression is also seen in the glnA mutant, 
albeit to a somewhat lower extent than in the glnR mutant. This could indicate that, in the 












































































































Figure 3. Expression of glnPQ and zwf in S. pneumoniae D39 (black bars) and glnR (white bars) and glnA 
(diagonally hatched bars) mutants in various media. (A) β-galactosidase activity in strains TK111 (D39nisRK 
PglnP-lacZ), TK121 (D39nisRK glnR-stop PglnP-lacZ) and TK127 (D39nisRK ∆glnA PglnP-lacZ) in the media 
as indicated on the x-axis (see Fig. 2 for abbreviations). (B) β-galactosidase activity in strains TK112 
(D39nisRK zwf-lacZ), TK123 (D39nisRK glnR-stop zwf-lacZ) and TK130 (D39nisRK ∆glnA zwf-lacZ) in the 
media indicated on the x-axis. (C) Zwf activity in D39, TK102 (D39 glnR-stop), TK103 (D39 ∆glnA) and 
TK107 (D39 ∆zwf, horizontally hatched bars) in GM17Gln. 
 
Regulation of zwf by GlnR and GlnA occurs via the glnP promoter 
The DNA microarray results showed that zwf, which lies downstream of glnPQ, is 
also upregulated in the glnR and glnA mutants. RT-PCR demonstrated that zwf lies on the 
same transcript as glnPQ and thus forms an operon with these genes (data not shown). To 
examine whether zwf is only transcribed from PglnP, or also from a possible promoter in the 
glnQ-zwf intergenic region, the latter was cloned upstream of lacZ in pORI13 and introduced 
in the RepA+ strain D39repA (161) and its glnR mutant. Promoter activity was present in this 
fragment (~5 Miller units), which was not dependent on GlnR (data not shown). Regulation 
of zwf by GlnR and GlnA was similar to, but weaker than regulation of glnPQ (Fig. 3B and 
C), which can be explained by the presence of the second promoter upstream of zwf. Thus, 
expression of zwf initiates from two promoters, a GlnR-dependent promoter upstream of glnP 
and a second promoter in the glnQ-zwf intergenic region.  
 
Regulation of gdhA by GlnR and CodY 
Despite the fully conserved GlnR operator in the gdhA promoter, regulation of gdhA 
by GlnR and GlnA in GM17Gln and CDM was weaker than regulation of glnPQ and glnRA 
(Fig. 4A and B). However, expression of an ectopic lacZ fusion to the full-length gdhA 
promoter (PgdhA-1) and to a truncated version without the GlnR box (PgdhA-2, see also Fig. 
1) showed that deletion of the predicted GlnR operator abolished the GlnR-dependent 
repression of PgdhA (Fig. 4C), demonstrating that the predicted GlnR operator in the gdhA 
promoter is functional. 
Interestingly, in the S. pneumoniae R6 genome putative CodY operator sequences are 
present in the promoter regions of, amongst others, gdhA and zwf (77). To examine whether 
CodY regulates these genes in S. pneumoniae, the activity of the corresponding enzymes was 
measured in a codY deletion mutant. No effect of the codY deletion was seen on the activity 
of Zwf in GM17Gln (data not shown), but activity of GdhA was strongly increased in the 
codY mutant (Fig. 4D). In a glnRcodY double mutant, GdhA activity was even higher than in 
the codY mutant, indicating that GlnR and CodY independently repress gdhA in S. 
pneumoniae (Fig. 4D). 
 

















































































































































































































Figure 4. Expression of gdhA in S. pneumoniae D39 and glnR, glnA and codY mutant derivatives. (A) β-
galactosidase activity in strains TK111 (D39nisRK gdhA-lacZ; black bars), TK121 (D39nisRK glnR-stop gdhA-
lacZ, white bars) and TK127 (D39nisRK ∆glnA gdhA-lacZ, hatched bars) in the media indicated on the x-axis 
(see Fig. 2 for abbreviations). (B) GdhA biosynthetic activity in D39 (black bar), TK102 (D39 glnR-stop, white 
bar), TK104 (D39 ∆glnA hatched bar) and TK129 (D39 ∆gdhA) strains in GM17Gln. (C) β-galactosidase 
activity in strains TK132 (D39 ∆bgaA::PgdhA-1-lacZ), TK133 (D39 ∆bgaA PgdhA-2-lacZ), TK134 (D39 glnR-
stop ∆bgaA::PgdhA-1-lacZ) and TK135 (D39 glnR-stop ∆bgaA::PgdhA-2-lacZ) grown in GM17Gln. Black bars 
represent D39 background and white bars the glnR mutant background. PgdhA-1, full-length gdhA promoter. 
PgdhA-2, gdhA promoter without the predicted GlnR operator. (D) GdhA activity in D39, TK102 (D39 glnR-















Figure 5. GlnPQ is the main glutamine/glutamate ABC transporter in S. pneumoniae D39. (A) Growth of D39 
(squares), TK106 (D39 ∆glnP, white triangles) and TK106 containing plasmid pTK17 (dotted line, nisin (2 
ng/ml) induced glnPQ expression; solid line, without nisin) in CDM with 1 mM glutamine. Crossed dotted line 
is growth of TK106 in CDM with 10 mM of the dipeptide Gly-Gln. (B) GlnA activity in strains D39 (black 
bars) and TK106 (white bars), grown in GM17, GM17Gln and GM17 with 2% casitone (GM17cas). 
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glnPQ in glutamine metabolism, a deletion of glnP, encoding the permease component of the 
GlnPQ ABC-transporter, was constructed in D39. Whereas S. pneumoniae D39 is able to 
grow in CDM containing glutamine (Fig. 5A) or glutamate (161), but not in their absence, the 
glnP mutant was not able to grow in CDM with either glutamine (Fig. 5A) or glutamate (data 
not shown). This phenotype could be complemented by in trans expression of glnPQ from a 
nisin-inducible promoter (Fig. 5A). Moreover, addition of the dipeptide Gly-Gln to the CDM 
also rescued growth of the glnP mutant (Fig. 5A), while this was not the case with the 
dipeptide Phe-Gly (data not shown). These data indicate that glnPQ encode the only actively 
expressed glutamine and glutamate uptake system in S. pneumoniae under these conditions. 
GlnA activity was increased in the glnP mutant in GM17 (Fig. 5B), although  to a 
lower extent as in the glnR mutant (Fig. 2B). To investigate whether regulation of glnA is 
affected in the glnP mutant, the effect of casitone as the nitrogen source in the medium was 
tested. Casitone, an enzymatic (pancreatic) digest of casein, consists of casein-derived 
peptides and contains no free glutamine and only a very low level of free glutamate 
(http://www.bd.com/ds/technicalCenter/misc/bionutrientmanual.pdf). Growth of the glnP 
mutant in CDM containing 2% casitone as the only nitrogen source was the same as that of 
the wild-type strain (data not shown), indicating that the uptake of peptides can by-pass the 
inability to take up glutamine and glutamate. The addition of casitone, like glutamine, to 
GM17 resulted in an approximately twofold reduced GlnA activity in the wild-type strain, but 
not in the glnP mutant (Fig. 5B). Thus, besides GlnA, also GlnPQ appear to be necessary for 
efficient repression by GlnR. 
 
Binding of GlnR to PglnP and PglnR is GlnA-dependent 
The transcriptional data presented above show that the activity of GlnR is dependent 
on GlnA. Therefore, we investigated whether GlnA is required for the binding of GlnR to the 
glnR and glnP promoters in vitro. For this we used a His-tagged variant of each protein (H6-
GlnA and H6-GlnR). Nisin-induced expression of H6-GlnA in strain TK100 restored growth 
in CDM with glutamate and no glutamine (data not shown). Nisin-induced expression of H6-
GlnR in the glnR mutant (TK105) led to fivefold lower GlnA activity in CDM with 5 mM 
glutamine and 10 mM ammonium (data not shown). In CDM with 10 mM glutamate, the 
level of repression was still fourfold, although the effect was weaker at low nisin-
concentration. With wild-type GlnR, the repressive effect was also fivefold in CDM with 5 
mM glutamine and 10 mM ammonium, but only twofold in CDM with 10 mM glutamate. 
These data indicate that H6-GlnA and H6-GlnR are functional, although the latter seems to 
respond in a less sensitive way to the concentrations of glutamate and glutamine.  
H6-GlnR alone at the concentration shown did not bind to PglnR and PglnP (Fig. 6A 
and B), also not in the presence of glutamine. However, in the presence of H6-GlnA, binding 
of H6-GlnR to PglnR and PglnP was observed (Fig. 6A and B). At a 5 to 10 times higher H6-
GlnR concentration (2 to 4 μM), a shifted band at the same position could be observed in the 
absence of H6-GlnA (data not shown), which corresponds with the transcriptional data, 
showing some weak repression by GlnR in the glnA mutant (Table 3, Fig. 3A). No binding of 
H6-GlnR was seen with the controls, the promoters without their GlnR operators (Fig. 6A and 
B). 
DNAse I footprinting showed that, in the presence of H6-GlnA, H6-GlnR specifically 
reduces DNAseI sensitivity of the predicted GlnR operator in PglnP (Fig. 6C and Fig. 1). 
Remarkably, the protected region in PglnR only partially overlapped with the predicted GlnR 
operator (Fig. 6B and Fig. 1), suggesting that GlnR binds in a different manner to this 
promoter than to PglnP. 
 
 



































































Figure 6. In vitro interaction of GlnR with the glnR and glnP 
promoters. (A), (B), EMSA of binding of GlnR to the glnR 
(PglnR-1) and glnP (PglnP-1) promoter regions and to 
truncated glnR (PglnR-2) and glnP (PglnP-2) promoters, 
lacking their respective GlnR operators. H6-GlnR, H6-GlnA 
were added as indicated above the panels in concentrations of 
400 nM (monomer*) and 1.5 μM (monomer*), respectively and 
glutamine (Gln), glutamate (Glu), ammonium (Am) and ATP 
were all added at 5 mM. The higher band seen for the free 
PglnR probe is probably single stranded DNA (76). (C) DNAseI 
footprint of PglnR and PglnP in the absence (-) and presence of 
400 nM H6-GlnR monomer* and 1.5 μM H6-GlnA monomer*. 
Glutamine was present in all reactions in a concentration of 5 
mM. Protected regions are indicated by black bars. Arrows 
indicate hypersensitive sites. Numbers on the left indicate bp 
positions relative to the translational starts of glnP and glnR. 
AG, Maxam-Gilbert sequence ladder. *GlnR is likely active as a 
dimer (44,50,108) and GlnA as a dodecamer (8). 
 
In contrast to what would be expected from the expression data, GlnA-dependent 
binding of GlnR to PglnP and PglnR was only weakly stimulated by the addition of 
glutamine (Fig. 6A and B). This could be explained by the observation mentioned above, that 
H6-GlnR seems to be less sensitive to glutamine than the native protein. Addition of the other 
GlnA substrates glutamate, ammonium, ATP and AMP alone or in combination did not alter 
the observed GlnA dependency of the GlnR-DNA interaction at PglnP (Fig. 6A). Thus, 
although GlnA is required for the binding of GlnR to the GlnR operators in the glnP and glnR 




















































Figure 7. Adhesion of S. pneumoniae strains TK136 (D39 ∆cps, WT), 
TK137 (D39 glnR-stop ∆cps, R), TK138 (D39 ∆glnA ∆cps, A), TK139 
(D39 ∆glnRA ∆cps, RA) and TK140 (D39 ∆glnP ∆cps, P) to Detroit 
562 human pharyngeal epithelial cells. Adhesion is given in % relative 










GlnA and GlnP contribute to adhesion to pharyngeal epithelial cells 
The crucial first step of pneumococcal infection is the colonization of the 
nasopharynx. Therefore, we tested the ability of glnR, glnA, glnRA and glnP mutants to 
adhere to the human pharyngeal epithelial cell line Detroit 562. These mutants were created 
in the capsuleless background strain D39 Δcps, as unencapsulated strains tend to show higher 
levels of adhesion ((249), data not shown). The glnP, glnA and glnRA mutants displayed a 
significantly decreased adhesion to the pharyngeal epithelial cells compared to the 
capsuleless wild-type strain (Fig. 7). Thus, both GlnP and GlnA could play a role in 
colonization of the nasopharynx. However, since most pneumococcal isolates are 





In this study, we characterized the regulation of glutamine and glutamate metabolism 
mediated by GlnR and GlnA in the human pathogen S. pneumoniae. Previously, GlnR-
dependent regulation of nitrogen metabolism has been thoroughly studied in B. subtilis. The 
only target that B. subtilis GlnR shares with GlnR from S. pneumoniae is glnRA (50). In 
addition, B. subtilis GlnR is a repressor of the ureABC operon (91,342) and tnrA (91), which 
are absent in S. pneumoniae (133). Another difference is that while GlnR is a repressor of 
glnPQ and gdhA in S. pneumoniae, in B. subtilis the catabolic glutamate dehydrogenase gene 
rocG is regulated by CcpA, RocR and AhrC (26), and the glnQH glutamine transport operon 
is activated by TnrA (348). 
We found that also expression of zwf, encoding a putative glucose-6-phosphate 
dehydrogenase, is regulated by GlnR. This enzyme catalyzes the first reaction in the pentose 
phosphate pathway, which provides the cell with NADPH and ribose-5-phosphate, a building 
block of nucleic acids. As glutamine is a precursor for the synthesis of nucleotides as well, it 
might be advantageous for S. pneumoniae to coordinate zwf expression with glutamine 
metabolism. 
Our data suggest that the regulation by S. pneumoniae GlnR depends on a conserved 
inverted repeat. The B. subtilis GlnR targets contain 2 copies of the same inverted repeat in 
their promoter regions (44,50). S. pneumoniae GlnR resembles B. subtilis TnrA in this 
respect, as TnrA activates or represses promoters containing only one copy of this repeat 
(348).  
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The distance between the GlnR operator and the -35 box in PglnR is 7 bp, for PglnP it 
is 16 bp. GlnR boxes are also present at a distance of 5 to 7 bp from the -35 in the glnR 
promoters of the S. pneumoniae relatives S. pyogenes, S. agalactiae and S. mutans. Moreover, 
GlnR operators are located in the glnP promoters of S. pyogenes and S. agalactiae, which, 
like in S. pneumoniae, have a 16 bp spacing with the -35 sequence. As the spacing in the glnP 
promoters is 9 to 10 bp longer than in the respective glnR promoters, regulation by GlnR via 
these operators might be helix-side dependent in these organisms. 
The GlnR operator in PgdhA confers a less pronounced GlnR-dependent effect than 
the GlnR operators in PglnP and PglnR, although the inverted repeat is perfectly conserved. 
The same accounts for the GlnR operator in ParcA. In PglnR and PglnP there is a stretch of A 
nucleotides immediately upstream of the repeat and a stretch of T nucleotides between the 
two half-sites. Since AT-rich stretches on these positions of B. subtilis PnrgAB enhance 
TnrA-dependent transcriptional activation (344), these stretches might explain the more 
efficient transcriptional repression of PglnP and PglnR than of ParcA and PgdhA, Both GlnR 
and CodY function as a repressor of gdhA in S. pneumoniae, of which CodY seems to be the 
more important regulator. Furthermore, both regulators control gdhA transcription 
independently of each other, which is in agreement with the location of their operators, that 
for CodY lying upstream of the -35 and the GlnR operator downstream of the -10 in PgdhA. 
In B. subtilis CodY controls the cellular nutritional and energy status (157,293). Although 
GdhA is obviously connected to glutamine metabolism, the observation that gdhA expression 
is, next to GlnR, also regulated by CodY in S. pneumoniae, might indicate that GdhA is an 
important control point of the cellular nutritional status in this bacterium. 
We show that GlnR DNA binding is dependent on GlnA, in contrast to the situation in 
B. subtilis, where GlnR alone binds with high affinity to its target promoters in the absence of 
any effectors (50). Since a high concentration of GlnR alone led to a shifted band at the same 
position as in the presence of GlnA, it is unlikely that GlnR and GlnA bind as a complex to 
the DNA. It might be that GlnA induces a conformational change or multimerization of 
GlnR, which increases its DNA binding affinity. Next to GlnA, also GlnP seems important 
for activity of S. pneumoniae GlnR. Although GlnR and GlnA alone were sufficient for in 
vitro binding to the glnP and glnR promoters, it could be that in vivo both GlnPQ and GlnA 
are needed for optimal activity of GlnR.  
Our results and previous STM screens (181,254) implicate a role for both GlnP and 
GlnA in pneumococcal adhesion to human pharyngeal cells, which is a prerequisite to invade 
the host. Previously, GlnQ was shown to be required for adhesion of S. pyogenes to 
fibronectin and epithelial cells of the respiratory tract (313). However, it remains to be 
investigated whether the effect of GlnPQ on adhesion by S. pneumoniae and S. pyogenes is 
caused by a general effect of distorted glutamine metabolism on e.g. the cell-surface 
composition or that GlnPQ are directly involved. We are currently analyzing glnR, glnA, 
glnP, and gdhA mutant strains in several in vivo mouse models, to get more insight in the role 





CDM, chemically defined medium; GM17, M17 containing 0.25% glucose. 
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